CVE record · CVE-2026-129953

NodePress through 8.5.1 Rate Limit Bypass via Spoofed X-Forwarded-For

CVSS 6.9 MediumEPSS 0.0020 · 9th percentile

Published by the CVE Program (CNA: VulnCheck) at 16 Nov 2026, 15:06 UTC. agentprime has not analysed this yet, so whether it affects any app is not known. This CVE names a vendor and product rather than a package, so the lockfile check doesn’t match it.

Affected products, as the CNA wrote them
VendorProductVersions
surmon-china NodePress pkg:github/surmon-china/nodepress
  • affected 8.5.1 and earlier semver
Other versions: unaffected
Identifiers
CVE-2026-129953
CNA
VulnCheck
Weakness (CWE)
CWE-348
Published
16 Nov 2026
Updated
16 Nov 2026

Machine-written summary

Summary written by Claude Haiku from the source advisory. Not reviewed by a person.

NodePress through 8.5.1 has a rate limit bypass: because trustProxy is enabled, an unauthenticated attacker can spoof the X-Forwarded-For header to evade throttling. This lets them brute-force the administrator password via the login endpoint and evade comment IP blocklists. The source gives no fixed version or workaround.

Written 21 Nov 2026.

Not analysed yet

We haven’t published our own analysis of this CVE. If a person reviews it, this page will say what’s affected and what has to be true for it to matter.

Severity and exploitation

ScoreRatingCVSSVectorSource
6.9 Medium 4.0 CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N CNA (VulnCheck)Used for this record
5.3 Medium 3.1 CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N CNA (VulnCheck)
  • CISA KEV Not listed.
  • EPSS 0.0020, the 9th percentile, on 22 Nov 2026: FIRST’s estimate of the chance of exploitation in the next 30 days.

Timeline

  1. 16 Nov 2026, 15:06 UTC Confirmed by the CVE List
  2. 16 Nov 2026, 15:17 UTC Confirmed by NVD
  3. 16 Nov 2026, 15:18 UTC First seen by agentprime

Sources

References from the CNA

Facts on this page come from the CVE List as the CNA published them, with CVSS from the sources named above, CISA KEV and FIRST EPSS. Vendors, products and versions are shown as the CNA wrote them. We don’t reproduce the CVE’s description.